ENDEFR
Home › India › ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED

ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED

Private Limited Company (Pvt Ltd) · Hyderabad, India · LEI 984500FDE6EAA05F8M49
LEI activegroup parent

Summary

ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED is registered in India and entered in the “Companies Register (Ministry of Corporate Affairs)” under number U24233TG2008PTC060606. Its legal form is Private Limited Company (Pvt Ltd). ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 5 Feb 2020 and the record was last updated on 9 Dec 2025; the next renewal is due by 5 Feb 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formPrivate Limited Company (Pvt Ltd)
RegisterCompanies Register (Ministry of Corporate Affairs) · Register website
Registration numberU24233TG2008PTC060606
Registration authorityMinistry of Corporate Affairs
JurisdictionIndia
Registered addressP. No. 53, ALEAP Industrial Estate, Gajularamaram, Behind Pragathi Nagar, Kukatpally, 500090 Hyderabad, India
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)13 Aug 2008
LEI984500FDE6EAA05F8M49
LEI statusactive
LEI first issued5 Feb 2020
LEI record last updated9 Dec 2025
Next LEI renewal5 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED this entity
INVITRON ADVANCED ANALYTICS PRIVATE LIMITED India

Parent not reported to GLEIF

  • Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
  • Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.

Direct subsidiaries (1)

Other names

  • M/S ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED · trading name